EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant Both patients treated with EDIT ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback